Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.

@article{Hermiller2005OutcomesWT,
  title={Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.},
  author={James Bernard Hermiller and Albert Raizner and Louis Cannon and Paul A Gurbel and Michael A. Kutcher and Shing Chiu Wong and Mary E. Russell and Stephen G. Ellis and Roxana Mehran and Gregg Whitney Stone},
  journal={Journal of the American College of Cardiology},
  year={2005},
  volume={45 8},
  pages={1172-9}
}
OBJECTIVES We sought to determine the safety and efficacy of polymer-regulated site-specific delivery of paclitaxel in patients with diabetes mellitus undergoing stent implantation. BACKGROUND Percutaneous coronary intervention in patients with diabetes is associated with high rates of restenosis and repeat revascularization due to excessive neointimal proliferation, a process that may be blunted with the site-specific delivery of paclitaxel. METHODS In the TAXUS-IV trial, 1,314 patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

Drug-eluting Stents bei Patienten mit Diabetes mellitus

Herz Kardiovaskuläre Erkrankungen • 2008
View 7 Excerpts
Highly Influenced

Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…